Bumper Offer - Urjas oil Just @ Rs. 1
Resteclin is a prescription drug, available for use as Tablet,Capsule. Primarily, it is used for the treatment of Bacterial Infections. Resteclin also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Resteclin. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Resteclin include Diarrhoea. Besides the aforementioned side effects, there are other adverse effects of Resteclin as well, which are listed below. Such side effects of Resteclin normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Resteclin has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Resteclin's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Resteclin have been discussed in the sections ahead.
Drug interactions for Resteclin have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Resteclin is not safe while driving, and is is not addictive in nature.
Resteclin is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Resteclin is used -
Severe
Moderate
Mild
Common
Is the use of Resteclin safe for pregnant women?
Resteclin can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Resteclin safe during breastfeeding?
Resteclin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Resteclin on the Kidneys?
Resteclin rarely affects the kidneys.
What is the effect of Resteclin on the Liver?
Resteclin has very mild side effects on the liver.
What is the effect of Resteclin on the Heart?
There are no any side effects of Resteclin for the heart.
Resteclin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Resteclin unless your doctor advises you to do so -
Is this Resteclin habit forming or addictive?
No, there is no any evidence that Resteclin is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Resteclin as you may feel sleepy.
Is it safe?
Yes, but take Resteclin only as per medical advice.
Is it able to treat mental disorders?
No, Resteclin is not used to treat mental disorders.
Interaction between Food and Resteclin
Taking Resteclin with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Resteclin
It is difficult to say anything about the effect of Resteclin and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Oracea® (doxycycline)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 733-739
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1193
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Oracea® (doxycycline)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 733-739
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1193
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Oracea® (doxycycline)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 733-739
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1193
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Oracea® (doxycycline)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 733-739
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1191-1193
